Retail giant Shinsegae Group's beauty select shop chain, Chicor, will showcase smart mirrors powered by AI technology dubbed the ‘Zmirror’ in a pop-up store to help customers choose their ideal skincare products.
The smart mirrors, which have a built-in camera and an under-the-mirror display, will diagnose their customer’s skin conditions, checking for dark circles, wrinkles, and elasticity to come up with recommendations for customers.
The recommended products will be sourced from the cosmetics brand Onoma’s lineup offered at Shinsegae Department Store.
Chicor's pop-up store, which it would initially open in Daejeon, would be divided into an experience zone and a sales zone.
The experience zone helps customers diagnose and analyze their skin through smart mirrors before recommending suitable skincare products in the sales zone.
Shinsegae said that the smart mirror service will be available in other stores later.


SpaceX Seeks FCC Approval for Massive Solar-Powered Satellite Network to Support AI Data Centers
Palantir Stock Jumps After Strong Q4 Earnings Beat and Upbeat 2026 Revenue Forecast
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom
The Beauty Beneath the Expressway: A Journey from Self to Service
Why have so few atrocities ever been recognised as genocide?
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
6 simple questions to tell if a ‘finfluencer’ is more flash than cash
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
The ghost of Robodebt – Federal Court rules billions of dollars in welfare debts must be recalculated
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Instagram Outage Disrupts Thousands of U.S. Users
Britain has almost 1 million young people not in work or education – here’s what evidence shows can change that
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



